Literature DB >> 1953785

Regulation of interleukin-1 beta production by glucocorticoids in human monocytes: the mechanism of action depends on the activation signal.

M Hurme1, P Siljander, H Anttila.   

Abstract

Glucocorticoids are known to downregulate interleukin-1 beta production in monocytic cells by two different mechanims: direct inhibition of the gene transcription and destabilization of the preformed interleukin-1 beta mRNA. Now we have examined the effect of the nature of the monocyte activating signal on these two inhibitory mechanims. When human monocytes were preincubated with dexamethasone for 1 hour and then stimulated either with bacterial lipopolysaccharide or phorbol myristate, it was found that dexamethasone inhibited the lipopolysaccharide-induced interleukin-1 beta protein production, but the phorbol myristate-induced production was increased 3-10 fold. This difference was also seen at the mRNA level. When dexamethasone was added to the cultures 3 hours after the stimulators, it clearly decreased the interleukin-1 beta mRNA levels regardless of the stimulator used (although the effect was clearly weaker on the PMA-induced mRNA). Thus these data suggest that the phorbol myristate-induced signal (prolonged protein kinase C activation?) cannot be inhibited by prior incubation with dexamethasone and it also protects the induced mRNA for the degradative action of dexamethasone.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1953785     DOI: 10.1016/s0006-291x(05)81349-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  A novel mechanism of glucocorticoid-induced immune suppression: the inhibiton of T cell-mediated terminal maturation of a murine dendritic cell line.

Authors:  T Kitajima; K Ariizumi; P R Bergstresser; A Takashima
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Suppression of IL-6 biological activities by activin A and implications for inflammatory arthropathies.

Authors:  E W Yu; K E Dolter; L E Shao; J Yu
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

3.  Induced expression of the new cytokine, activin A, in human monocytes: inhibition by glucocorticoids and retinoic acid.

Authors:  J Yu; L E Shao; N L Frigon; J Lofgren; R Schwall
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

4.  Signal transduction pathways leading to the production of IL-8 by human monocytes are differentially regulated by dexamethasone.

Authors:  H S Anttila; S Reitamo; M Ceska; M Hurme
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

5.  Cloning and analysis of gene regulation of a novel LPS-inducible cDNA.

Authors:  C G Lee; N A Jenkins; D J Gilbert; N G Copeland; W E O'Brien
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

6.  Glucocorticoids as cytokine inhibitors: role in neuroendocrine control and therapy of inflammatory diseases.

Authors:  G Fantuzzi; P Ghezzi
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

7.  Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates.

Authors:  Sohee Jeon; Won Ki Lee
Journal:  Clin Ophthalmol       Date:  2014-08-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.